ArticleJournal for immunotherapy of cancer2022

GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma.

Tessa Gargett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.